Campbell & Co Investment Adviser’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
CAMG
ECM
RHJA
Campbell & Co Investment Adviser's CLB Position: Q2 2026 in Review
Campbell & Co Investment Adviser sold out of Core Laboratories (CLB) in Q2 2026, closing a stake of 40,374 shares — an estimated $678K sold.
Campbell & Co Investment Adviser first reported a position in CLB in Q2 2013 and held it in 12 quarters. The position peaked at $2.37M in Q2 2014. 77 funds tracked by Wall St. Rank hold CLB as of Q2 2026.
- Campbell & Co Investment Adviser reported no remaining Core Laboratories position as of Q2 2026 after selling out during the quarter.
- Campbell & Co Investment Adviser sold 40,374 Core Laboratories shares in Q2 2026, an estimated $678K.
- Campbell & Co Investment Adviser first reported a position in Core Laboratories in Q2 2013 and held it in 12 quarters.
- Campbell & Co Investment Adviser's Core Laboratories position peaked at $2.37M in Q2 2014.
- 77 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.
Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.